RT Book, Section A1 Hoffman, Barbara L. A1 Schorge, John O. A1 Halvorson, Lisa M. A1 Hamid, Cherine A. A1 Corton, Marlene M. A1 Schaffer, Joseph I. SR Print(0) ID 1171532888 T1 Preinvasive Lesions of the Lower Anogenital Tract T2 Williams Gynecology, 4e YR 2020 FD 2020 PB McGraw-Hill Education PP New York, NY SN 9781260456868 LK obgyn.mhmedical.com/content.aspx?aid=1171532888 RD 2024/03/28 AB Office gynecology includes the diagnosis and management of preinvasive lower anogenital tract (LAGT) disease, most often involving the uterine cervix, but also the vulvar, vaginal, perianal, and anal epithelia. An understanding of human papillomavirus (HPV) as the causative agent of most LAGT neoplasia has greatly advanced screening, diagnosis, management, and prevention efforts. Importantly, in current clinical practice, evidence-based knowledge is ever evolving and translates into rapidly changing patient-care recommendations. Although most study findings and clinical guidelines to date refer to women, these are applicable to the care of some transgender men (Hembree, 2017).